Items where Author is "Haschke, M."

2017

Erb, S. and Letang, E. and Glass, T. R. and Natamatungiro, A. and Mnzava, D. and Mapesi, H. and Haschke, M. and Duthaler, U. and Berger, B. and Muri, L. and Bader, J. and Marzolini, C. and Elzi, L. and Klimkait, T. and Langewitz, W. and Battegay, M. and Kilombero Ulanga Antiretroviral Cohort study group, . (2017) Health care provider communication training in rural Tanzania empowers HIV-infected patients on antiretroviral therapy to discuss adherence problems. HIV medicine, 18 (9). pp. 623-634.

2016

Berger, B. and Donzelli, M. and Maseneni, S. and Boess, F. and Roth, A. and Krahenbuhl, S. and Haschke, M.. (2016) Comparison of Liver Cell Models Using the Basel Phenotyping Cocktail. Front Pharmacol, 7. p. 443.

Derungs, A. and Donzelli, M. and Berger, B. and Noppen, C. and Krahenbuhl, S. and Haschke, M.. (2016) Effects of Cytochrome P450 Inhibition and Induction on the Phenotyping Metrics of the Basel Cocktail: A Randomized Crossover Study. Clin Pharmacokinet, 55 (1). pp. 79-91.

Meier, S. and Haschke, M. and Zahner, C. and Kruttschnitt, E. and Drewe, J. and Schaedelin, S. and Gaab, J.. (2016) Effects of a fixed herbal drug combination (Ze 185) to an experimental acute stress setting in healthy men - an explorative randomized placebo-controlled double blind study. Planta Medica , 81 (1). pp. 1-381.

2012

Hardmeier, M. and Zimmermann, R. and Rüegg, S. and Pflüger, M. and Deuster, S. and Suter, K. and Donzelli, M. and Drewe, J. and Krähenbühl, S. and Fuhr, P. and Haschke, M.. (2012) Intranasal midazolam: pharmacokinetics and pharmacodynamics assessed by quantitative EEG in healthy volunteers. Clinical Pharmacology & Therapeutics, 91 (5). pp. 856-862.

2010

Egger, S. S. and Meier, S. and Leu, C. and Christen, S. and Gratwohl, A. and Krahenbuhl, S. and Haschke, M.. (2010) Drug interactions and adverse events associated with antimycotic drugs used for invasive aspergillosis in hematopoietic SCT. Bone marrow transplantation, Vol. 45, H. 7. pp. 1197-1203.

Taegtmeyer, A. B. and Zettler, C. and Siegemund, M. and Tsakiris, D. A. and Rätz Bravo, A. E. and Pargger, H. and Kraehenbuehl, S. and Haschke, M.. (2010) Iloprost-induced thrombocytopenia: a case proven by rechallenge. The European respiratory journal, Vol. 36, H. 4. pp. 967-969.

Haschke, M. and Vitins, T. and Lude, S. and Todesco, L. and Novakova, K. and Herrmann, R. and Krahenbuhl, S.. (2010) Urinary excretion of carnitine as a marker of proximal tubular damage associated with platin-based antineoplastic drugs. Nephrology, dialysis, transplantation, Vol. 25, H. 2. pp. 426-433.

2009

Bodmer, M. and Haschke, M. and Bravo, Rätz and Liechti, M. E.. (2009) Nierenversagen und hämolytische Anämie = Acute renal failure due to rifampicine. Schweizerische Rundschau für Medizin Praxis, Jg. 98, Nr. 4. pp. 179-185.

2008

Bodmer, M. and Burkard, T. and Kummer, O. and Beyrau, R. and Krähenbühl, S. and Haschke, M.. (2008) Pharmacokinetics and pharmacodynamics of quetiapine in a patient with a massive overdose. Therapeutic drug monitoring, Vol. 30, H. 4. pp. 553-556.

Bodmer, M. and Link, B. and Grignaschi, N. and Kummer, O. and Ruegg, S. and Haschke, M. and Krähenbühl, S.. (2008) Pharmacokinetics of midazolam and metabolites in a patient with refractory status epilepticus treated with extraordinary doses of midazolam. Therapeutic drug monitoringNew York : Raven Press, Vol. 30, H. 1. pp. 120-124.

Kummer, O. and Hammann, F. and Bodmer, M. and Novakova, K. and Krähenbühl, S. and Haschke, M.. (2008) [Drug-induced toxic hepatitis]. Schweizerische Rundschau für Medizin PRAXIS, Vol. 97 , S. 235-239 ; quiz 240-241.

2007

Lampert, M. L. and Rätz Bravo, A. E. and Brugger, S. and Haschke, M.. (2007) Ungewöhlicher Wirkungsverlust von Oxcarbazepin. PRAXIS, 96 (47). pp. 1843-1848.

2006

Kummer, O. and Haschke, M. and Tuchscherer, D. and Lampert, M. and Martius, F. and Krähenbühl, S.. (2006) Agranulozytose bei einem mit Metamizol und Clopidogrel behandelten Patienten. PRAXIS, 95 (45). pp. 1743-1747.